Description
Data Available
To access this data, please log into DSS and submit an application. Within the application, add this dataset (accession NG00117) in the “Choose a dataset” section. Once approved, you will be able to log in and access the data within the DARM portal.
Description
The NCRAD Families sample set was genotyped at the Children’s Hospital of Philadelphia using the Illumina Infinium GSAMD-24v2-0_20024620_A1 BeadChip which captures genotype data on 759,993 genomic SNPs. These families are not evaluated in person. Family history and demographic data are collected and updated annually. Clinical information is obtained through the request for medical records which are reviewed by a central neurologist and where possible, diagnosis is determined by NINCDS-ADRDA Criteria. A standardized telephone cognitive battery is completed, where possible, every 2 years. These data are also reviewed centrally along with the medical records. Subjects are contacted annually for updates on diagnoses within their family. Brain donation is coordinated for interested participants and performed centrally. Brain tissue is available from some NCRAD Family Study participants.
Sample Summary per Data Type
| Sample Set | Accession | Data Type | Number of Samples |
|---|---|---|---|
| NCRAD Families GWAS GSA | snd10037 | GWAS | 698 |
Available Filesets
| Name | Accession | Latest Release | Description |
|---|---|---|---|
| NCRAD Families GWAS | fsa000032 | NG00117.v1 | GWAS, Covariates, Phenotypes |
View the File Manifest for a full list of files released in this dataset.
Subject Information
The NCRAD Families sample set was genotyped at the Children's Hospital of Philadelphia using the Illumina Infinium GSAMD-24v2-0_20024620_A1 BeadChip which captures genotype data on 759,993 genomic SNPs.
| Sample Set | Accession Number | Number of Subjects |
|---|---|---|
| NCRAD Families GWAS GSA | snd10037 | 698 |
Related Studies
Consent Levels
| Consent Level | Number of Subjects |
|---|---|
| GRU-IRB-PUB | 698 |
Visit the Data Use Limitations page for definitions of the consent levels above.
Acknowledgement
Acknowledgment statement for any data distributed by NIAGADS:
Data for this study were prepared, archived, and distributed by the National Institute on Aging Alzheimer’s Disease Data Storage Site (NIAGADS) at the University of Pennsylvania (U24-AG041689), funded by the National Institute on Aging.
Use the study-specific acknowledgement statements below (as applicable):
For investigators using any data from this dataset:
Please cite/reference the use of NIAGADS data by including the accession NG00117.
For investigators using NCRAD Family Study (sa000025) data:
Samples from the National Centralized Repository for Alzheimer’s Disease and Related Dementias (NCRAD), which receives government support under a cooperative agreement grant (U24AG021886) awarded by the National Institute on Aging (NIA), were used in this study. We thank the participants and their families, whose help and participation made this work possible.
For use of data in ng00117: Quality control procedures and data preparation on the GWAS was conducted by the Alzheimer’s Disease Genetics Consortium (ADGC) (UO1AG032984) and the NIA Genetics of Alzheimer’s Disease Storage Site (NIAGADS) (U24-AG041689), both funded by NIA.
For use of data in ng00129: Data processing and quality control procedures on the whole-exome dataset was conducted by the Genome Center for Alzheimer’s Disease (GCAD) (U54AG052427) and the NIA Genetics of Alzheimer’s Disease Storage Site (NIAGADS) (U24-AG041689), both funded by NIA.